Upgrade to SI Premium - Free Trial

Allarity Therapeutics (ALLR)

1.42 -0.01 (0.70%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

Form 8-K Allarity Therapeutics, For: Aug 14 August 14, 2026 4:39 PM - SEC Filing Form 10-Q Allarity Therapeutics, For: Jun 30 August 14, 2026 8:03 AM - SEC Filing Allarity reports Q2 2026 results, completes stenoparib manufacturing August 14, 2026 8:00 AM - StreetInsider Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign August 14, 2026 8:00 AM - StreetInsider Allarity gets CLIA certification for its Denmark lab July 7, 2026 8:03 AM - StreetInsider Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration July 7, 2026 8:00 AM - StreetInsider Form 8-K Allarity Therapeutics, For: Jun 26 July 1, 2026 8:06 AM - SEC Filing Allarity gets U.S. patent for stenoparib companion diagnostic June 30, 2026 8:01 AM - StreetInsider Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic June 30, 2026 8:00 AM - StreetInsider Form 8-K Allarity Therapeutics, For: Jun 18 June 22, 2026 8:10 AM - SEC Filing Allarity to present stenoparib Phase 2 poster at ESMO congress June 18, 2026 8:00 AM - StreetInsider Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026 June 18, 2026 8:00 AM - StreetInsider Full Article List